Also categorized in BoardMoves:
Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
x hide permanently

KalVista Pharmaceuticals Appoints Daniel B. Soland to Board of Directors

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, announced today that Daniel Soland has been appointed to its Board of Directors effective immediately. Mr. Soland most recently served as the Chief Executive Officer of uniQure N.V. and Senior Vice President and Chief Operating Officer of ViroPharma...

Mentions: Nasdaq Daniel Soland KalVista Pharmaceuticals